 BOSTON, Nov. 08, 2022 GLOBE NEWSWIRE -- Compass Therapeutics, Inc. Nasdaq: CMPX, a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced it will be presenting at the following investor conferences during the month of November 2022. 